Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Advik Laboratories Ltd

NSE: ADVIKLA · BSE: 531686 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹2.08
Market cap
₹3.98 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-1.02 Cr
P/E (TTM)
-3.8×Sector 47.3×
Promoter holding
35.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:14 IST BSE
Other Announcement

Advik Laboratories Other Announcement

MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.

16:53 IST BSE
Annual General Meeting

Advik Laboratories Annual General Meeting

The company submitted its 32nd Annual Report and AGM notice for FY 2025-26. The meeting is scheduled for September 29, 2026.

17:17 IST BSE
Board Meeting Outcome

Advik Laboratories Board Meeting Outcome

MPS Pharmaa Ltd announced the outcome of its board meeting, fixing the 32nd AGM date and recommending new director and auditor appointments for shareholder approval.

18:26 IST BSE
Board Meeting Date

Advik Laboratories Board Meeting Date

MPS Pharmaa Limited has scheduled a board meeting on September 02, 2026, to consider the notice for the company's upcoming Annual General Meeting.

16:58 IST BSE
Board Meeting Date

Advik Laboratories Board Meeting Date

MPS Pharmaa Limited will hold a board meeting on August 13, 2026, to consider and approve the company's un-audited financial results for the quarter ending June 30, 2026.

13:42 IST BSE
Other Announcement

Advik Laboratories Other Announcement

Advik Laboratories Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing provides the distribution of shares among promoters and public shareholders.